Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway

Hypertension

Volumn 54, Issue 5, 2009, Pages 1077-1083

  Yao, Bing ^a   Harris, Raymond C ^a   Zhang, Ming Zhi ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclooxygenase 2; Dopamine; Hypertension; Kidney; Oxidative stress; Prostaglandin E2

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CATECHOL METHYLTRANSFERASE; CYCLOOXYGENASE 2; DEOXYCORTICOSTERONE ACETATE; DOPAMINE; PROSTAGLANDIN E2; SODIUM; BENZAZEPINE DERIVATIVE; DEOXYCORTICOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIURESIS; HYPERTENSION; MOUSE; NATRIURESIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; ANALYSIS OF VARIANCE; ANIMAL; BLOOD PRESSURE MEASUREMENT; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; KIDNEY MEDULLA; METABOLISM; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PROBABILITY; RANDOMIZATION; SALT INTAKE; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BENZAZEPINES; BLOOD PRESSURE DETERMINATION; BLOTTING, WESTERN; CYCLOOXYGENASE 2; DESOXYCORTICOSTERONE; DINOPROSTONE; DISEASE MODELS, ANIMAL; DOPAMINE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY MEDULLA; MICE; MICE, KNOCKOUT; PROBABILITY; RANDOM ALLOCATION; SODIUM CHLORIDE, DIETARY;

EID: 70449706327     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.137174     Document Type: Article

References (45)

1. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics. 2004;19:233-246.
2. Aperia AC. Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol. 2000;62:621-647.
3. Carey RM. Theodore Cooper Lecture: renal dopamine system-paracrine regulator of sodium homeostasis and blood pressure. Hypertension. 2001; 38:297-302.
4. Wang X, Villar VA, Armando I, Eisner GM, Felder RA, Jose PA. Dopamine, kidney, and hypertension: studies in dopamine receptor knockout mice. Pediatr Nephrol. 2008;23:2131-2146.
5. Zelenina M, Zelenin S, Bondar AA, Brismar H, Aperia A. Water permeability of aquaporin-4 is decreased by protein kinase C and dopamine. Am J Physiol Renal Physiol. 2002;283:F309-F318.
6. Felder RA, Jose PA. Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol. 2006;2:637-650.
7. Shin Y, Kumar U, Patel Y, Patel SC, Sidhu A. Differential expression of D2-like dopamine receptors in the kidney of the spontaneously hypertensive rat. J Hypertens. 2003;21:199-207. (Pubitemid 36143525)
8. Sidhu A, Kumar U, Uh M, Patel S. Diminished expression of renal dopamine D1A receptors in the kidney inner medulla of the spontaneously hypertensive rat. J Hypertens. 1998;16:601-608.
9. Helkamaa T, Mannisto PT, Rauhala P, Cheng ZJ, Finckenberg P, Huotari M, Gogos JA, Karayiorgou M, Mervaala EM. Resistance to salt-induced hypertension in catechol-O-methyltransferase-gene-disrupted mice. J Hypertens. 2003;21:2365-2374.
10. Armando I, Wang X, Villar VA, Jones JE, Asico LD, Escano C, Jose PA. Reactive oxygen species-dependent hypertension in dopamine D2 receptor-deficient mice. Hypertension. 2007;49:672-678.
11. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Escano CS, Wang X, Quinn MT, Sibley DR, Romero GG, Felder RA, Jose PA. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol. 2006;290: R96-R104.
12. Needleman P, Douglas JR Jr, Jakschik B, Stoecklein PB, Johnson EM Jr. Release of renal prostaglandin by catecholamines: relationship to renal endocrine function. J Pharmacol Exp Ther. 1974;188:453-460.
13. Tai HH, Tai CL, Hollander CS. Biosynthesis of prostaglandins in rabbit kidney medulla: properties of prostaglandin synthase. Biochem J. 1976; 154:257-264.
14. Harris RC. COX-2 and the kidney. J Cardiovasc Pharmacol. 2006; 47(suppl 1):S37-S42.
15. Zhang MZ, Yao B, Fang X, Wang S, Smith JP, Harris RC. Intrarenal dopaminergic system regulates renin expression. Hypertension. 2009;53: 564-570.
16. Cheng HF, Wang JL, Zhang MZ, Miyazaki Y, Ichikawa I, McKanna JA, Harris RC. Angiotensin II attenuates renal cortical cyclooxygenase-2 expression. J Clin Invest. 1999;103:953-961.
17. Yao B, Harris RC, Zhang MZ. Interactions between 11beta-hydroxysteroid dehydrogenase and COX-2 in kidney. Am J Physiol Regul Integr Comp Physiol. 2005;288:R1767-R1773.
18. Morrow JD, Roberts LJ. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res. 1997;36:1-21.
19. Zhang MZ, Yao B, Cheng HF, Wang SW, Inagami T, Harris RC. Renal cortical cyclooxygenase 2 expression is differentially regulated by angio-tensin II AT(1) and AT(2) receptors. Proc Natl Acad Sci U S A. 2006; 103:16045-16050.
20. Zhang MZ, Wang JL, Cheng HF, Harris RC, McKanna JA. Cyclooxy-genase-2 in rat nephron development. Am J Physiol. 1997;273: F994-F1002.
21. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest. 1994;94:2504-2510.
22. Zhang MZ, Yao B, McKanna JA, Harris RC. Cross talk between the intrarenal dopaminergic and cyclooxygenase-2 systems. Am J Physiol Renal Physiol. 2005;288:F840-F845.
23. Fujii A, Nakano D, Katsuragi M, Ohkita M, Takaoka M, Ohno Y, Matsumura Y. Role of gp91phox-containing NADPH oxidase in the deoxycorticosterone acetate-salt-induced hypertension. Eur J Pharmacol. 2006;552:131-134.
24. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, Cohen RA. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res. 2001;88:947-953.
25. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
26. Shen B, Hagiwara M, Yao Y-Y, Chao L, Chao J. Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress. Hypertension. 2008;51:1358-1365.
27. Zhang A, Jia Z, Guo X, Yang T. Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin. Am J Physiol Renal Physiol. 2007;293:F723-F731.
28. Yasunari K, Kohno M, Kano H, Minami M, Yoshikawa J. Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D(1)-like receptors. Circulation. 2000;101:2302-2308.
29. Cosentino M, Rasini E, Colombo C, Marino F, Blandini F, Ferrari M, Samuele A, Lecchini S, Nappi G, Frigo G. Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: evidence for a D1-like receptor-dependent protective effect. Free Radic Biol Med. 2004;36:1233-1240.
30. Asghar M, Chillar A, Lokhandwala MF. Renal proximal tubules from old Fischer 344 rats grow into epithelial cells in cultures and exhibit increased oxidative stress and reduced D1 receptor function. Am J Physiol Cell Physiol. 2008;295:C1326-C1331.
31. Banday AA, Lau Y-S, Lokhandwala MF. Oxidative stress causes renal dopamine D1 receptor dysfunction and salt-sensitive hypertension in Sprague-Dawley rats. Hypertension. 2008;51:367-375.
32. Zeng C, Villar VAM, Yu P, Zhou L, Jose PA. Reactive oxygen species and dopamine receptor function in essential hypertension. Clin Exp Hypertens. 2009;31:156-178.
33. Zhang MZ, Hao CM, Breyer MD, Harris RC, McKanna JA. Mineralo-corticoid regulation of cyclooxygenase-2 expression in rat renal medulla. Am J Physiol Renal Physiol. 2002;283:F509-F516.
34. Stokes JB. Integrated actions of renal medullary prostaglandins in the control of water excretion. Am J Physiol. 1981;240:F471-F480.
35. Horton R, Bughi S, Jost-Vu E, Antonipillai I, Nadler J. Effect of dopamine on renal blood flow, prostaglandins, renin and electrolyte excretion in normal and hypertensive humans. Am J Hypertens. 1990;3:108S-111S.
36. Huo T, Ye MQ, Healy DP. Characterization of a dopamine receptor (DA2K) in the kidney inner medulla. Proc Natl Acad Sci USA. 1991; 88:3170-3174.
37. Rodriguez F, Llinas MT, Gonzalez JD, Rivera J, Salazar FJ. Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake. Hypertension. 2000;36:276-281.
38. Viel EC, Benkirane K, Javeshghani D, Touyz RM, Schiffrin EL. Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol. 2008;295:H281-H288.
39. Wu R, Millette E, Wu L, de Champlain J. Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxy-corticosterone acetate-salt hypertensive rats. J Hypertens. 2001;19:741-748.
40. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Bai RK, Sibley DR, Felder RA, Jose PA. D5 dopamine receptor regulation of phospholipase D. Am J Physiol Heart Circ Physiol. 2005;288:H55-H61.
41. Jose PA, Eisner GM, Felder RA. Dopamine and the kidney: a role in hypertension? Curr Opin Nephrol Hypertens. 2003;12:189-194.
42. Pedrosa R, Jose PA, Soares-da-Silva P. Defective D1-like receptor-mediated inhibition of the Cl-/HCO3" exchanger in immortalized SHR proximal tubular epithelial cells. Am J Physiol Renal Physiol. 2004;286: F1120-F1126.
43. Cheng HF, Becker BN, Harris RC. Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest. 1996;97:2745-2752.
44. Guyton AC. Blood pressure control: special role of the kidneys and body fluids. Science. 1991;252:1813-1816.
45. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA. 2006;103:17985-17990